Lifestyle & Healthslider Five Year Follow-Up Data of Pfizer’s CROWN Trial Shows Prolonged Progression-Free Survival in ALK-Positive Advanced Lung Cancer by Karine Ayoub June 3, 2024 by Karine Ayoub June 3, 2024 An unprecedented 60% of patients remain alive without disease progression after five years Updated… 0 FacebookTwitterPinterestEmail